"""Builds the institutional-grade deep-dive research prompt for a single stock.

Pure string templating (no streamlit import, per CLAUDE.md convention) so it stays
testable and reusable outside the UI. The template itself is the 18-section analyst
memo format the user standardized on — see the prompt text below for the full spec.
"""

_TEMPLATE = """Detailed research report
You are a world-class equity analyst conducting deep fundamental research on {company}. Your goal is to produce an institutional-grade investment memo that leaves no stone unturned.

### 1. Business Deep Dive
* What is the business and business model? Where does it fit in the value chain between its suppliers and customers? Explain to a layman.
* What is each business segment about? Break down revenue contribution by segment.
* What are the key products/services? Explain the end-use applications.
* What is the company's go-to-market strategy (B2B vs B2C, direct vs distributor, licensing vs owned)?
* Identify the critical dependencies in the business model (key customers, suppliers, regulatory approvals).

---

### 2. Industry & Competitive Positioning
* What is the competitive landscape in the industry? Analyze through Michael Porter's 5 Forces lens.
* Identify industry trends mentioned (pricing, demand, regulation, technology shifts).
* Assess company positioning vs competitors — is it a leader, challenger, or niche player?
* Look for signs of pricing power or commoditization.
* Identify barriers to entry, moats, or erosion signals.
* What is the industry growth rate (TAM/SAM/SOM if available)?

### 3. Peer Comparison (CRITICAL FOR RELATIVE VALUATION)
* Identify 4-6 closest listed peers with similar business models, product lines, or end markets.
* Create a detailed peer comparison table including:
  - Market Cap
  - Revenue & Revenue Growth (3-year CAGR)
  - EBITDA Margin
  - PAT Margin
  - ROE / ROCE
  - P/E (TTM & Forward)
  - EV/EBITDA
  - P/B
  - Debt/Equity
  - Geographic revenue mix
  - Key differentiators vs the company being analyzed
* Highlight where the company is better/worse than peers and why.
* Is the current valuation premium/discount justified relative to peers?

---

### 4. Product & Revenue Concentration Analysis
* What are the top 5-10 products/SKUs by revenue contribution?
* What percentage of revenue comes from the top 3 products?
* Are any key products facing:
  - Patent expiry or generic competition?
  - Regulatory risks (price caps, bans)?
  - Customer concentration (single large buyer)?
* Which products have the highest margins vs lowest margins?
* What is the product lifecycle stage of key offerings (growth, maturity, decline)?

---

### 5. Pipeline & Future Growth Visibility
* What is the R&D or product development pipeline?
* Break down pipeline by:
  - Stage (early development, filed, approved, launched)
  - Therapeutic area / category
  - Expected launch timeline
  - Addressable market size for each pipeline product
* What is the R&D spend as % of revenue? How does it compare to peers?
* Are there any first-to-market or differentiated pipeline opportunities?
* What is the historical success rate of pipeline conversion to commercial products?
* Identify any partnerships, licensing deals, or collaborations for pipeline products.

---

### 6. Business Performance
* What are the key KPIs in the business that drive performance?
* Break down performance across segments, geographies, and products.
* What factors influenced performance so far?
* Identify key growth drivers vs temporary tailwinds.
* Separate cyclical vs structural growth.
* Highlight any changes in business mix and why they matter.
* Analyze margins (gross, EBITDA, PAT) and drivers of expansion/contraction.
* Calculate and analyze working capital cycle (debtor days, inventory days, payable days, cash conversion cycle).

---

### 7. Analyst Q&A Goldmine
* Extract the most important questions asked by analysts in recent earnings calls.
* Identify repeated concerns across analysts.
* Analyze how management responds under pressure.
* Highlight any questions avoided or answered vaguely.
* What are analysts most bullish/bearish about?

---

### 8. Management Commentary Analysis (MOST IMPORTANT)
* Identify tone shifts vs previous quarters (if implied).
* Detect optimism vs caution vs defensiveness.
* Highlight what management is NOT saying (missing disclosures).
* Identify hedging language, vague statements, or overconfidence.
* Extract forward-looking statements and assess credibility.
* Would you be comfortable giving money to this management? Why or why not?

---

### 9. Management & Promoter Track Record (CRITICAL FOR TRUST)
* Who are the promoters and key management personnel?
* What is their educational and professional background?
* What companies have they built, managed, or been associated with before this?
* Any previous successes or failures? Any controversies?
* How long have key executives been with the company?
* What is management compensation relative to company size and profitability?
* Any recent management departures or additions? Why?
* Is there professional management or is it a promoter-run family business?
* Promoter holding trend — increasing, stable, or decreasing over last 3 years?
* Any promoter pledging? If yes, what % and trend?
* Related party transactions — nature, quantum, and whether arms-length.
* Any SEBI/legal actions against promoters or management?

---

### 10. Capital Allocation & Strategy
* Analyze capex plans: scale, timing, expected returns.
* Assess ROI clarity (are they giving IRR/asset turns/payback period?).
* Evaluate acquisitions, divestments, partnerships.
* Comment on capital allocation discipline vs empire building.
* Dividend policy and payout history.
* Buyback history and rationale.
* How has management allocated capital in the past and what were the returns?

---

### 11. Financial Quality & Red Flags
* Look for inconsistencies in numbers or commentary.
* Identify aggressive accounting signals (revenue recognition, capitalization policies, provisions).
* Flag working capital stress, debt issues, or cash flow mismatch.
* Highlight any one-off adjustments masking real performance.
* CFO vs PAT comparison — is cash profit matching reported profit?
* Contingent liabilities and off-balance sheet items.
* Auditor observations or qualifications.
* Any related party transactions that seem unusual?
* Tax rate vs statutory rate — any unexplained gaps?

---

### 12. Shareholding Pattern & Institutional Activity
* Current shareholding breakdown (Promoter, FII, DII, MF, Retail).
* Change in shareholding over last 4 quarters.
* Which prominent mutual funds or institutions hold the stock?
* Any recent bulk/block deals?
* Pledging status and trend.

---

### 13. Guidance & Future Outlook (DETAILED ANSWERS NEEDED WITH WHY)
* Extract explicit and implicit guidance.
* Break down assumptions behind guidance.
* Identify risks to guidance (internal + external).
* Evaluate whether guidance is conservative or aggressive.
* What would need to go right/wrong for guidance to be met/missed?

---

### 14. Variant Perception (CRITICAL FOR INVESTING EDGE)
* What is the market likely misunderstanding about this company?
* What are potential upside triggers not fully priced in?
* What are key downside risks the market may be ignoring?
* Where is consensus vs where is reality?
* What would change the narrative?

---

### 15. Scenario Building
Build 3 scenarios with explicit assumptions:

**Bull Case:**
* Assumptions (growth rates, margins, catalysts)
* Revenue, EBITDA, PAT projections
* Valuation multiple and target price
* What needs to go right?

**Base Case:**
* Realistic expectations
* Revenue, EBITDA, PAT projections
* Valuation multiple and fair value
* Most likely outcome

**Bear Case:**
* What goes wrong?
* Revenue, EBITDA, PAT projections
* Valuation multiple and downside price
* Key risks that could trigger this

For each scenario, make Revenue, EBITDA/Operating Profit, and PAT assumptions based on subtle hints from management commentary.

---

### 16. Valuation Analysis
* Current valuation multiples (P/E, EV/EBITDA, P/B, P/S).
* Historical valuation range (5-year high/low multiples).
* Peer comparison multiples.
* DCF valuation with explicit assumptions (if sufficient data available).
* What is priced in at current levels?
* Margin of safety assessment.
---

### 17. Key Quotes (Evidence-Based Analysis)
* Extract the most important questions from analysts and quotes from management.
* Use quotes to support your conclusions.
* Include both bullish and cautionary quotes.
---
### 18. Management walk the talk
include walk the talk table about what they guided in the past regarding topline and EBITDA margins and what they delivered with colour code of last 6-8 quarters and last 5 years both separately in two different tables ( consolidated numbers). If it is a IPO or does not have long history then pull out as long as back data is available
—
### 18.
make a FF style colourful docx - mentioned in the top - Key trigger and key monitorable, key risks and why stock is moving then afterward make a whole detail report so that i get sense in the first one page. Avoid any direct buy-sell recommendation section. Ask me if you have any doubt

### Output Format
* Write in a structured, professional investor memo format.
* Avoid fluff; prioritize insight density.
* Be critical, not agreeable.
* Write detailed answers with context, not small bullet points.
* Use tables for data comparison wherever helpful.
* Clearly distinguish between facts and your interpretation/opinion.
* Highlight red flags and risks prominently.
* End with a clear, actionable investment conclusion.
"""


def build_deep_dive_prompt(ticker: str, sector: str = "") -> str:
    """Fill the 18-section analyst-memo template for one screener hit.

    `ticker` is the raw screener ticker (e.g. "TANLA", "MRPL" — no exchange suffix).
    `sector` is optional context folded into the company label so the researcher
    doing the deep dive (a human, or Claude in a follow-up chat) isn't starting cold.
    """
    company = f"{ticker} ({sector})" if sector else ticker
    return _TEMPLATE.format(company=company)
